Prime Medicine

#6575

Rank

$673.46M

Marketcap

United States

Country

Leadership team

Dr. Keith Michael Gottesdiener M.D. (Pres, CEO, Sec. & Director)

Dr. Ann L. Lee Ph.D. (Chief Technical Officer)

Dr. Jeremy S. Duffield M.D., Ph.D. (Chief Scientific Officer)

Products/ Services

Biotechnology, Genetics, Life Science, Medical

Headquarters

Cambridge, Massachusetts, United States

Established

2019

Company Registration

SEC CIK number: 0001894562

Traded as

PRME

Social Media

URL

https://www.primemedicine.com

Overview

Location

Recognition and Award

References

Summary

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

History

Established in 2007, our roots go back to 2009 when we partnered with a few small companies to form our current enterprise. Since then, we have grown to be one of the leading companies in the industry, with products and services spanning 50 countries.

Mission

We’re committed to helping people get the medicine they need to feel better and live well. This mission fuels our passion and drives every decision we make.

Vision

To be a trusted leader in the industry and a beacon of innovation, providing quantitative solutions to health and wellness.

Key Team

Dr. Andrew Anzalone M.D., Ph.D. (Co-Founder, Sr. Scientist II, Head of Prime Editing Platform & Head of Platform Devel.)

Ms. Niamh Alix (Chief HR Officer)

Mr. Richard Brudnick (Chief Bus. Officer)

Dr. David R. Liu Ph.D. (Co-Founder & Chair of Scientific Advisory Board)

Ms. Carman Alenson CPA, M.B.A. (Chief Accounting Officer & Interim CFO)

Dr. Meredith Goldwasser (Sr. VP of Strategy & Corp. Operations and Head of Strategy & Corp. Operations)

Dr. Karen Brown J.D., Ph.D. (Sr. VP of Intellectual Property & Legal Affairs)

Recognition and Awards

Prime Medicine has been recognized with numerous industry awards, including Pharmaceuticals Company of the Year, Most Innovative Company of the Year, and Fastest Growing Company of the Year